 Connection
Keila Lopez to Risk Factors
This is a "connection" page, showing publications Keila Lopez has written about Risk Factors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.432 |
|
|
|
-
Jordan CAL, Alizadeh F, Ramirez LS, Kimbro R, Lopez KN. Obesity in Pediatric Congenital Heart Disease: The Role of Age, Complexity, and Sociodemographics. Pediatr Cardiol. 2023 Aug; 44(6):1251-1261.
Score: 0.073
-
Kovacs AH, Vervoort D, Lopez KN. Moving beyond lifestyle: the case for childhood adversity, social determinants of health, and psychosocial factors in cardiovascular risk prediction. Eur Heart J. 2023 02 14; 44(7):594-597.
Score: 0.073
-
Lynn MM, Salemi JL, Kostelyna SP, Morris SA, Tejtel SKS, Lopez KN. Lesion-Specific Congenital Heart Disease Mortality Trends in Children: 1999 to 2017. Pediatrics. 2022 10 01; 150(4).
Score: 0.071
-
Lopez KN, Nembhard WN, Wang Y, Liu G, Kucik JE, Copeland G, Gilboa SM, Kirby RS, Canfield M. Birth defect survival for Hispanic subgroups. Birth Defects Res. 2018 03 01; 110(4):352-363.
Score: 0.051
-
Brewer M, Kimbro RT, Denney JT, Osiecki KM, Moffett B, Lopez K. Does neighborhood social and environmental context impact race/ethnic disparities in childhood asthma? Health Place. 2017 03; 44:86-93.
Score: 0.048
-
Burns J, Lopez KN, Stephens SB, Deen JF. Obesity and Left Ventricular Function in American Indian Adolescents: Strong Heart Family Study. J Racial Ethn Health Disparities. 2025 Dec; 12(6):4262-4270.
Score: 0.020
-
Opotowsky AR, Khairy P, Diller G, Kasparian NA, Brophy J, Jenkins K, Lopez KN, McCoy A, Moons P, Ollberding NJ, Rathod RH, Rychik J, Thanassoulis G, Vasan RS, Marelli A. Clinical Risk Assessment and Prediction in Congenital Heart Disease Across the Lifespan: JACC Scientific Statement. J Am Coll Cardiol. 2024 May 28; 83(21):2092-2111.
Score: 0.020
-
Sood E, Newburger JW, Anixt JS, Cassidy AR, Jackson JL, Jonas RA, Lisanti AJ, Lopez KN, Peyvandi S, Marino BS. Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association. Circulation. 2024 03 26; 149(13):e997-e1022.
Score: 0.020
-
Broda CR, Salciccioli KB, Lopez KN, Ermis PR, Moodie DS, Dickerson HA. Outcomes in adults with congenital heart disease and heterotaxy syndrome: A single-center experience. Congenit Heart Dis. 2019 Nov; 14(6):885-894.
Score: 0.014
-
Heo JH, Rascati KL, Lopez KN, Moffett BS. Increased Fracture Risk with Furosemide Use in Children with Congenital Heart Disease. J Pediatr. 2018 08; 199:92-98.e10.
Score: 0.013
-
Shamshirsaz AA, Bateni ZH, Sangi-Haghpeykar H, Arian SE, Erfani H, Shamshirsaz AA, Abuhamad A, Fox KA, Ramin SM, Moaddab A, Maskatia SA, Salmanian B, Lopez KN, Hosseinzadeh P, Schutt AK, Nassr AA, Espinoza J, Dildy GA, Belfort MA, Clark SL. Cyanotic congenital heart disease following fertility treatments in the United States from 2011 to 2014. Heart. 2018 06; 104(11):945-948.
Score: 0.013
-
Mery CM, Lopez KN, Molossi S, Sexson-Tejtel SK, Krishnamurthy R, McKenzie ED, Fraser CD, Cantor SB. Decision analysis to define the optimal management of athletes with anomalous aortic origin of a coronary artery. J Thorac Cardiovasc Surg. 2016 11; 152(5):1366-1375.e7.
Score: 0.012
-
Foraker RE, Patten CA, Lopez KN, Croghan IT, Thomas JL. Beliefs and attitudes regarding smoking among young adult Latinos: a pilot study. Prev Med. 2005 Jul; 41(1):126-33.
Score: 0.005
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|